Nuclear Medicine Radiopharmaceuticals-United States Market Status and Trend Report 2013-2023
Report Summary
Nuclear Medicine Radiopharmaceuticals-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Nuclear Medicine Radiopharmaceuticals industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
United States Nuclear Medicine Radiopharmaceuticals Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Nuclear Medicine Radiopharmaceuticals Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diagnostic
Brachytherapy
Other Therapeutic
United States Nuclear Medicine Radiopharmaceuticals Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Oncology
Thyroid
Cardiology
Others
United States Nuclear Medicine Radiopharmaceuticals Market: Players Segment Analysis (Company and Product introduction, Nuclear Medicine Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin):
Mallinckrodt
Isorad
Cardinal Health
Jubilant
Medi-Radiopharma
Comecer
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Nuclear Medicine Radiopharmaceuticals-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Nuclear Medicine Radiopharmaceuticals industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
- Whole United States and Regional Market Size of Nuclear Medicine Radiopharmaceuticals 2013-2017, and development forecast 2018-2023
- Main market players of Nuclear Medicine Radiopharmaceuticals in United States, with company and product introduction, position in the Nuclear Medicine Radiopharmaceuticals market
- Market status and development trend of Nuclear Medicine Radiopharmaceuticals by types and applications
- Cost and profit status of Nuclear Medicine Radiopharmaceuticals, and marketing status
- Market growth drivers and challenges
United States Nuclear Medicine Radiopharmaceuticals Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Nuclear Medicine Radiopharmaceuticals Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diagnostic
Brachytherapy
Other Therapeutic
United States Nuclear Medicine Radiopharmaceuticals Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Oncology
Thyroid
Cardiology
Others
United States Nuclear Medicine Radiopharmaceuticals Market: Players Segment Analysis (Company and Product introduction, Nuclear Medicine Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin):
Mallinckrodt
Isorad
Cardinal Health
Jubilant
Medi-Radiopharma
Comecer
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
1.1 Definition of Nuclear Medicine Radiopharmaceuticals in This Report
1.2 Commercial Types of Nuclear Medicine Radiopharmaceuticals
1.2.1 Diagnostic
1.2.2 Brachytherapy
1.2.3 Other Therapeutic
1.3 Downstream Application of Nuclear Medicine Radiopharmaceuticals
1.3.1 Oncology
1.3.2 Thyroid
1.3.3 Cardiology
1.3.4 Others
1.4 Development History of Nuclear Medicine Radiopharmaceuticals
1.5 Market Status and Trend of Nuclear Medicine Radiopharmaceuticals 2013-2023
1.5.1 United States Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023
1.5.2 Regional Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Nuclear Medicine Radiopharmaceuticals in United States 2013-2017
2.2 Consumption Market of Nuclear Medicine Radiopharmaceuticals in United States by Regions
2.2.1 Consumption Volume of Nuclear Medicine Radiopharmaceuticals in United States by Regions
2.2.2 Revenue of Nuclear Medicine Radiopharmaceuticals in United States by Regions
2.3 Market Analysis of Nuclear Medicine Radiopharmaceuticals in United States by Regions
2.3.1 Market Analysis of Nuclear Medicine Radiopharmaceuticals in New England 2013-2017
2.3.2 Market Analysis of Nuclear Medicine Radiopharmaceuticals in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Nuclear Medicine Radiopharmaceuticals in The Midwest 2013-2017
2.3.4 Market Analysis of Nuclear Medicine Radiopharmaceuticals in The West 2013-2017
2.3.5 Market Analysis of Nuclear Medicine Radiopharmaceuticals in The South 2013-2017
2.3.6 Market Analysis of Nuclear Medicine Radiopharmaceuticals in Southwest 2013-2017
2.4 Market Development Forecast of Nuclear Medicine Radiopharmaceuticals in United States 2018-2023
2.4.1 Market Development Forecast of Nuclear Medicine Radiopharmaceuticals in United States 2018-2023
2.4.2 Market Development Forecast of Nuclear Medicine Radiopharmaceuticals by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Nuclear Medicine Radiopharmaceuticals in United States by Types
3.1.2 Revenue of Nuclear Medicine Radiopharmaceuticals in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Nuclear Medicine Radiopharmaceuticals in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Nuclear Medicine Radiopharmaceuticals in United States by Downstream Industry
4.2 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Major Countries
4.2.1 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in New England
4.2.2 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in The Midwest
4.2.4 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in The West
4.2.5 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in The South
4.2.6 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Southwest
4.3 Market Forecast of Nuclear Medicine Radiopharmaceuticals in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
5.1 United States Economy Situation and Trend Overview
5.2 Nuclear Medicine Radiopharmaceuticals Downstream Industry Situation and Trend Overview
CHAPTER 6 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Nuclear Medicine Radiopharmaceuticals in United States by Major Players
6.2 Revenue of Nuclear Medicine Radiopharmaceuticals in United States by Major Players
6.3 Basic Information of Nuclear Medicine Radiopharmaceuticals by Major Players
6.3.1 Headquarters Location and Established Time of Nuclear Medicine Radiopharmaceuticals Major Players
6.3.2 Employees and Revenue Level of Nuclear Medicine Radiopharmaceuticals Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Mallinckrodt
7.1.1 Company profile
7.1.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.1.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Mallinckrodt
7.2 Isorad
7.2.1 Company profile
7.2.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.2.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Isorad
7.3 Cardinal Health
7.3.1 Company profile
7.3.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.3.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Cardinal Health
7.4 Jubilant
7.4.1 Company profile
7.4.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.4.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jubilant
7.5 Medi-Radiopharma
7.5.1 Company profile
7.5.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.5.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Medi-Radiopharma
7.6 Comecer
7.6.1 Company profile
7.6.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.6.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Comecer
7.7 Jaco
7.7.1 Company profile
7.7.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.7.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jaco
7.8 Ciaeriar
7.8.1 Company profile
7.8.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.8.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Ciaeriar
7.9 Advanced Molecular-imaging Solution
7.9.1 Company profile
7.9.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.9.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Advanced Molecular-imaging Solution
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
8.1 Industry Chain of Nuclear Medicine Radiopharmaceuticals
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
9.1 Cost Structure Analysis of Nuclear Medicine Radiopharmaceuticals
9.2 Raw Materials Cost Analysis of Nuclear Medicine Radiopharmaceuticals
9.3 Labor Cost Analysis of Nuclear Medicine Radiopharmaceuticals
9.4 Manufacturing Expenses Analysis of Nuclear Medicine Radiopharmaceuticals
CHAPTER 10 MARKETING STATUS ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Nuclear Medicine Radiopharmaceuticals in This Report
1.2 Commercial Types of Nuclear Medicine Radiopharmaceuticals
1.2.1 Diagnostic
1.2.2 Brachytherapy
1.2.3 Other Therapeutic
1.3 Downstream Application of Nuclear Medicine Radiopharmaceuticals
1.3.1 Oncology
1.3.2 Thyroid
1.3.3 Cardiology
1.3.4 Others
1.4 Development History of Nuclear Medicine Radiopharmaceuticals
1.5 Market Status and Trend of Nuclear Medicine Radiopharmaceuticals 2013-2023
1.5.1 United States Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023
1.5.2 Regional Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Nuclear Medicine Radiopharmaceuticals in United States 2013-2017
2.2 Consumption Market of Nuclear Medicine Radiopharmaceuticals in United States by Regions
2.2.1 Consumption Volume of Nuclear Medicine Radiopharmaceuticals in United States by Regions
2.2.2 Revenue of Nuclear Medicine Radiopharmaceuticals in United States by Regions
2.3 Market Analysis of Nuclear Medicine Radiopharmaceuticals in United States by Regions
2.3.1 Market Analysis of Nuclear Medicine Radiopharmaceuticals in New England 2013-2017
2.3.2 Market Analysis of Nuclear Medicine Radiopharmaceuticals in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Nuclear Medicine Radiopharmaceuticals in The Midwest 2013-2017
2.3.4 Market Analysis of Nuclear Medicine Radiopharmaceuticals in The West 2013-2017
2.3.5 Market Analysis of Nuclear Medicine Radiopharmaceuticals in The South 2013-2017
2.3.6 Market Analysis of Nuclear Medicine Radiopharmaceuticals in Southwest 2013-2017
2.4 Market Development Forecast of Nuclear Medicine Radiopharmaceuticals in United States 2018-2023
2.4.1 Market Development Forecast of Nuclear Medicine Radiopharmaceuticals in United States 2018-2023
2.4.2 Market Development Forecast of Nuclear Medicine Radiopharmaceuticals by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Nuclear Medicine Radiopharmaceuticals in United States by Types
3.1.2 Revenue of Nuclear Medicine Radiopharmaceuticals in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Nuclear Medicine Radiopharmaceuticals in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Nuclear Medicine Radiopharmaceuticals in United States by Downstream Industry
4.2 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Major Countries
4.2.1 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in New England
4.2.2 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in The Midwest
4.2.4 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in The West
4.2.5 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in The South
4.2.6 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Southwest
4.3 Market Forecast of Nuclear Medicine Radiopharmaceuticals in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
5.1 United States Economy Situation and Trend Overview
5.2 Nuclear Medicine Radiopharmaceuticals Downstream Industry Situation and Trend Overview
CHAPTER 6 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Nuclear Medicine Radiopharmaceuticals in United States by Major Players
6.2 Revenue of Nuclear Medicine Radiopharmaceuticals in United States by Major Players
6.3 Basic Information of Nuclear Medicine Radiopharmaceuticals by Major Players
6.3.1 Headquarters Location and Established Time of Nuclear Medicine Radiopharmaceuticals Major Players
6.3.2 Employees and Revenue Level of Nuclear Medicine Radiopharmaceuticals Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Mallinckrodt
7.1.1 Company profile
7.1.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.1.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Mallinckrodt
7.2 Isorad
7.2.1 Company profile
7.2.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.2.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Isorad
7.3 Cardinal Health
7.3.1 Company profile
7.3.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.3.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Cardinal Health
7.4 Jubilant
7.4.1 Company profile
7.4.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.4.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jubilant
7.5 Medi-Radiopharma
7.5.1 Company profile
7.5.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.5.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Medi-Radiopharma
7.6 Comecer
7.6.1 Company profile
7.6.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.6.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Comecer
7.7 Jaco
7.7.1 Company profile
7.7.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.7.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jaco
7.8 Ciaeriar
7.8.1 Company profile
7.8.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.8.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Ciaeriar
7.9 Advanced Molecular-imaging Solution
7.9.1 Company profile
7.9.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.9.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Advanced Molecular-imaging Solution
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
8.1 Industry Chain of Nuclear Medicine Radiopharmaceuticals
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
9.1 Cost Structure Analysis of Nuclear Medicine Radiopharmaceuticals
9.2 Raw Materials Cost Analysis of Nuclear Medicine Radiopharmaceuticals
9.3 Labor Cost Analysis of Nuclear Medicine Radiopharmaceuticals
9.4 Manufacturing Expenses Analysis of Nuclear Medicine Radiopharmaceuticals
CHAPTER 10 MARKETING STATUS ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
